Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citation
Cited by
Items 401–500 of 1,024
Genomics and emerging biomarkers for immunotherapy of colorectal cancer
Kather, J. N., Halama, N., & Jaeger, D. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.010 · Cited by 150
“(89-91) In a broad definition of the term “stroma”, it refers to all non-cancerous cells in the tumor.”
BackgroundHeterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
Bauer, M., Su, G., Casper, C., He, R., Rehrauer, W., & Friedl, A. (2010) · Oncogene · doi:10.1038/onc.2009.463 · Cited by 172
“CAF are likely derived from resident fibroblasts and marrow-derived mesenchymal precursor cells, while their generation via epithelial mesenchymal transition of tumor cells is more controversial (Kalluri and Zeisberg, 2006; Karnoub et al., 2007; Mishra et al., 2008; Mueller and Fusenig, 2004), TGFβ and PDGF are though…”
BackgroundMesenchymal stroma: Role in osteosarcoma progression
Cortini, M., Avnet, S., & Baldini, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.024 · Cited by 171
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D., & Prockop, D. J. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201012-071dw · Cited by 171
Polireddy, K., Dong, R., Reed, G., Yu, J., Chen, P., Williamson, S., Violet, P.-C., Pessetto, Z., Godwin, A. K., Fan, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17568-8 · Cited by 149
Immunological properties of mesenchymal stem cells and clinical implications
Patel, S. A., Sherman, L., Munoz, J., & Rameshwar, P. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0001-x · Cited by 170
“In a recent study, MSCs have been shown to promote breast cancer metastasis in an experimental model [24].”
BackgroundBreast cancer stem cells: Multiple capacities in tumor metastasis
Geng, S.-Q., Alexandrou, A. T., & Li, J. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.036 · Cited by 170
“It is even proposed that normal stem cells promote the process of tumorigenesis, tumor metastasis, as well as CSCs dynamic change [28].”
BackgroundMorandi, F., Raffaghello, L., Bianchi, G., Meloni, F., Salis, A., Millo, E., Ferrone, S., Barnaba, V., & Pistoia, V. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0878 · Cited by 153
Mesenchymal Stem Cells: Angels or Demons?
Wong, R. S. Y. (2011) · BioMed Research International · doi:10.1155/2011/459510 · Cited by 149
“Chemokines secreted by MSCs have been shown to enhance the emergence of pulmonary metastases and such secretion has a strong interaction between breast cancer cells and MSCs [72].”
BackgroundHoshino, A., Ishii, G., Ito, T., Aoyagi, K., Ohtaki, Y., Nagai, K., Sasaki, H., & Ochiai, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3228 · Cited by 155
“It has been reported that bone-marrow-derived MSCs can promote breast cancer metastasis in vivo (25).”
Backgroundc-Jun Induces Mammary Epithelial Cellular Invasion and Breast Cancer Stem Cell Expansion
Jiao, X., Katiyar, S., Willmarth, N. E., Liu, M., Ma, X., Flomenberg, N., Lisanti, M. P., & Pestell, R. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100792 · Cited by 169
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
“For instance, human ovarian cancer-derived MSC showed higher pro-tumor growth activity than normal human BM-MSC and ASC, promoting the acquisition of a phenotype resembling putative cancer stem cells (CSC) [45], in support of local tumor-MSC crosstalk leading to specialized tumor-resident MSC populations.”
BackgroundInfluentialTGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
Drabsch, Y., & ten Dijke, P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9217-1 · Cited by 168
“Bonemarrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft [68].”
BackgroundThe Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
Bonollo, F., Thalmann, G. N., Kruithof-de Julio, M., & Karkampouna, S. (2020) · Cancers · doi:10.3390/cancers12071887 · Cited by 168
“However, some studies have demonstrated that CAFs can also have alternative origins: bone marrow-derived mesenchymal stem cells or adipocytes can be recruited to the TME and converted into CAFs [35,36].”
BackgroundTumor stroma derived biomarkers in cancer
Sund, M., & Kalluri, R. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9175-2 · Cited by 168
“This chemokine then acts in a paracrine fashion on the cancer cells, leading to a higher metastatic potential through increased motility and invasiveness in a reversible fashion [30].”
BackgroundCancer-associated fibroblasts: how do they contribute to metastasis?
Kwa, M. Q., Herum, K. M., & Brakebusch, C. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09959-0 · Cited by 169
p38MAPK plays a crucial role in stromal-mediated tumorigenesis
Alspach, E., Flanagan, K. C., Luo, X., Ruhland, M. K., Huang, H., Pazolli, E., Donlin, M. J., Marsh, T., Piwnica-Worms, D., Monahan, J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0743 · Cited by 167
“The TME plays a pivotal role in tumor progression, and recent expression analyses indicate that TME-specific expression changes are predictive of clinical outcome (1) (2) (3).”
InfluentialDe Boeck, A., Pauwels, P., Hensen, K., Rummens, J.-L., Westbroek, W., Hendrix, A., Maynard, D., Denys, H., Lambein, K., Braems, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301393 · Cited by 167
Role of myeloid cells in tumor angiogenesis and growth
Shojaei, F., Zhong, C., Wu, X., Yu, L., & Ferrara, N. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.06.003 · Cited by 167
Gao, Z., Zhang, L., Hu, J., & Sun, Y. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.06.003 · Cited by 167
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 171
CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer
Zhang, Q., Qin, J., Zhong, L., Gong, L., Zhang, B., Zhang, Y., & Gao, W. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3590 · Cited by 167
Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein
Qian, H., Le Blanc, K., & Sigvardsson, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339622 · Cited by 151
Heterogeneity of Tumor Endothelial Cells
Ohga, N., Ishikawa, S., Maishi, N., Akiyama, K., Hida, Y., Kawamoto, T., Sadamoto, Y., Osawa, T., Yamamoto, K., Kondoh, M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.035 · Cited by 166
Läubli, H., Spanaus, K.-S., & Borsig, L. (2009) · Blood · doi:10.1182/blood-2008-10-186585 · Cited by 166
Shangguan, L., Ti, X., Krause, U., Hai, B., Zhao, Y., Yang, Z., & Liu, F. (2012) · STEM CELLS · doi:10.1002/stem.1251 · Cited by 146
Galland, S., & Stamenkovic, I. (2020) · The Journal of Pathology · doi:10.1002/path.5357 · Cited by 165
“[10] Bone marrow Human Breast cancer Promoting CCL5 (RANTES) [11] Bone marrow Human Breast cancer Promoting p-EGFR [12] Bone marrow Human Prostate cancer Promoting TGF-β [13] Adipose tissue Human Prostate cancer Promoting TGF-β and periostin [14] Umbilical cord and adipose tissue Human Breast cancer Suppressive Apopto…”
BackgroundCCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Singh, S. K., Mishra, M. K., Eltoum, I.-E. A., Bae, S., Lillard, J. W., & Singh, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-19643-0 · Cited by 165
Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities
Lin, W., Huang, L., Li, Y., Fang, B., Li, G., Chen, L., & Xu, L. (2019) · BioMed Research International · doi:10.1155/2019/2820853 · Cited by 165
“It has been demonstrated in a number of preclinical in vitro migration experiments and in various tumor models, such as hepatoma [72], leukemia cells [73], breast cancer [52], and osteosarcoma [74].”
BackgroundKong, X., Du, Y., Wang, G., Gao, J., Gong, Y.-F., Li, L., Zhang, Z., Zhu, J., Jing, Q., Qin, Y., et al. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1285-3 · Cited by 165
“Since ‘‘tumor is a wound that never heals’’ [12, 13] and highly expressed miRNAs in specific tissues”
Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., Bosco, R., Ingrao, S., Zavan, B., & Zauli, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011140 · Cited by 148
“. The deleterious effects could derive from different MSC characteristics. Indeed, MSC specifically migrate toward sites of active tumorigenesis, where they could integrate the specialized tumor niche, contribute to the development of tumor-associated fibroblasts and myofibroblasts”
BackgroundPotential application of mesenchymal stem cells in acute lung injury
Lee, J. W., Gupta, N., Serikov, V. B., & Matthay, M. A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903213651 · Cited by 166
“Also, there have been reports of MSC enhancing the metastatic potential of solid tumors, such as breast cancer in mouse models [106,107].”
BackgroundKatanov, C., Lerrer, S., Liubomirski, Y., Leider-Trejo, L., Meshel, T., Bar, J., Feniger-Barish, R., Kamer, I., Soria-Artzi, G., Kahani, H., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0080-7 · Cited by 138
“Recent studies indicate that CAFs and MSCs promote malignancy through the expression of inflammatory chemokines [4,54-65].”
BackgroundStromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 147
“The gene expression profiles of GSE8977 (61), GSE9014 (62),”
BackgroundCancer-associated fibroblasts: The chief architect in the tumor microenvironment
Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 166
“In contrast, the transition from adipocytes has also been described (Karnoub et al., 2007; Nieman et al., 2011; Bochet et al., 2013).”
BackgroundChronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F. A., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 164
Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Fujiwara, T., Fukushi, J.-I., Yamamoto, S., Matsumoto, Y., Setsu, N., Oda, Y., Yamada, H., Okada, S., Watari, K., Ono, M., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.034 · Cited by 164
Zhao, Q., Gregory, C. A., Lee, R. H., Reger, R. L., Qin, L., Hai, B., Park, M. S., Yoon, N., Clough, B., McNeill, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423008112 · Cited by 164
Meier, R. P. H., Müller, Y. D., Morel, P., Gonelle-Gispert, C., & Bühler, L. H. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.08.011 · Cited by 153
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 151
Kulesza, A., Paczek, L., & Burdzinska, A. (2023) · Biomedicines · doi:10.3390/biomedicines11020445 · Cited by 163
“It has been proven that MSCs play a significant role in the formation, growth, progression and metastasis of neoplastic cells [136,137].”
BackgroundToward modeling the bone marrow niche using scaffold-based 3D culture systems
Di Maggio, N., Piccinini, E., Jaworski, M., Trumpp, A., Wendt, D. J., & Martin, I. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.041 · Cited by 163
Barderas, R., Bartolomé, R. A., Fernandez-Aceñero, M. J., Torres, S., & Casal, J. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4090 · Cited by 163
“Dissemination and metastasis of cancer cells depend on extensive interactions within the tumor microenvironment (2-3).”
BackgroundAnton, K., Banerjee, D., & Glod, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035036 · Cited by 141
“MSCs differentiate into a CAF phenotype within the tumor microenvironment and support solid tumor growth and metastasis [33,34].”
BackgroundSulpice, L., Rayar, M., Desille, M., Turlin, B., Fautrel, A., Boucher, E., Llamas-Gutierrez, F., Meunier, B., Boudjema, K., Clément, B., et al. (2013) · Hepatology · doi:10.1002/hep.26577 · Cited by 153
“(30-32) In liver cancers, tumor onset and formation are associated with important stromal changes, including fibrosis/cirrhosis and ECM remodeling.”
BackgroundMesenchymal stem cells and their use as cell replacement therapy and disease modelling tool
García-Castro, J., Trigueros, C., Madrenas, J., Pérez‐Simón, J. A., Rodríguez, R., & Menéndez, P. R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00516.x · Cited by 163
“Likewise, the presence of MSCs in the tumour stroma could facilitate breast cancer metastasis [111] or the growth of syngeneic tumours [112, 113] due, in part, to the high migration and mobility associated to a mesenchymal/fibroblastoid phenotype.”
BackgroundHow cancer cells dictate their microenvironment: present roles of extracellular vesicles
Naito, Y., Yoshioka, Y., Yamamoto, Y., & Ochiya, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2346-3 · Cited by 148
The immunomodulatory properties of mesenchymal stem cells
Marigo, I., & Dazzi, F. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0267-7 · Cited by 162
“In adoptive transfer experiments, MSC cause weakly metastatic human breast carcinoma cells to acquire potent metastatic ability [82].”
BackgroundImaging angiogenesis and the microenvironment
FUKUMURA, D., & JAIN, R. K. (2008) · APMIS · doi:10.1111/j.1600-0463.2008.01148.x · Cited by 162
“Furthermore, mesenchymal stem cells increase breast cancer metastasis via secretion of CCL5/RANTES (86).”
BackgroundZischek, C., Niess, H., Ischenko, I., Conrad, C., Huss, R., Jauch, K.-W., Nelson, P. J., & Bruns, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bd62d0 · Cited by 162
“Once there, MSCs contribute to the diverse cell types that comprise tumor stroma including the cells that comprise the tumor vasculature and stromal fibroblast-like cells.(5,12,16) Karnoub et al recently demonstrated that in breast cancer, MSCs are recruited to the tumor environment where they induce expression of the…”
BackgroundLuo, J., Lee, S., Liang, L., Huang, C.-K., Li, L., Wen, S., & Chang, C. (2013) · Oncogene · doi:10.1038/onc.2013.233 · Cited by 163
Natural and synthetic nanovectors for cancer therapy
Eftekhari, A., Kryschi, C., Pamies, D., Güleç, Ş., Ahmadian, E., Janas, D. W., Davaran, S., & Khalilov, R. I. (2023) · Nanotheranostics · doi:10.7150/ntno.77564 · Cited by 162
“For example, MSCs can boost breast cancer metastasis (152).”
Zabouo, G., Imbert, A., Jacquemier, J. D., Finetti, P., Moreau, T., Esterni, B., Birnbaum, D., Bertucci, F., & Chabannon, C. (2009) · Breast Cancer Research · doi:10.1186/bcr2215 · Cited by 162
“Overexpression of CCL5 in MDA-MB-231 cells enhances their metastatic potential [44].”
Backgroundde Girolamo, L., Lucarelli, E., Alessandri, G., Antonietta Avanzini, M., Ester Bernardo, M., Biagi, E., Teresa Brini, A., D’Amico, G., Fagioli, F., Ferrero, I., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130015 · Cited by 161
“In vitro and in vivo experimental studies have documented that murine MSCs are prone to malignant transformation [103]; moreover they may support tumor growth and metastatic spread [104].”
Lucchinetti, E., Awad, A. E., Rahman, M., Feng, J., Lou, P.-H., Zhang, L., Ionescu, L., Lemieux, H., Thébaud, B., & Zaugg, M. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824babfe · Cited by 161
Eterno, V., Zambelli, A., Pavesi, L., Villani, L., Zanini, V., Petrolo, G., Manera, S., Tuscano, A., & Amato, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1359 · Cited by 161
Chan, T.-S., Hsu, C.-C., Pai, V. C., Liao, W.-Y., Huang, S.-S., Tan, K.-T., Yen, C.-J., Hsu, S.-C., Chen, W.-Y., Shan, Y.-S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151665 · Cited by 161
“…such as breast cancer and pancreatic ductal adenocarcinoma (PDAC) are characterized by a pro nounced stromal reaction termed the desmoplastic response that can promote tumor progression and aggression (Liotta and Kohn, 2001; Orimo et al., 2005; Karnoub et al., 2007; Shiao and Coussens, 2010).”
BackgroundCancer stem cell targeted therapy: progress amid controversies
Wang, T., Shigdar, S. L., Gantier, M. P., Hou, Y., Wang, L., Li, Y., Shamaileh, H. A., Yin, W., Zhou, S., Zhao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6176 · Cited by 162
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
Barbie, T. U., Alexe, G., Aref, A. R., Li, S., Zhu, Z., Zhang, X., Imamura, Y., Thai, T. C., Huang, Y., Bowden, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75661 · Cited by 148
Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells
Cahu, J., Bustany, S., & Sola, B. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.183 · Cited by 160
“Increased tumorigenesis might be associated with an increase in cancer cell migration.(21) Having identified the chemokine RANTES as being secreted by non-CSLCs, we”
BackgroundThe key role of extracellular vesicles in the metastatic process
Zhao, H., Achreja, A., Iessi, E., Logozzi, M., Mizzoni, D., Di Raimo, R., Nagrath, D., & Fais, S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.005 · Cited by 160
Sung, S.-Y., Hsieh, C.-L., Law, A., Zhau, H. E., Pathak, S., Multani, A. S., Lim, S., Coleman, I. M., Wu, L.-C., Figg, W. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2492 · Cited by 160
“Karnoub and colleagues (46) reported the increase of CCL5 expression in tumor-associated stromal cells through direct contact with cancer epithelial cells.”
BackgroundZhang, T., Tseng, C., Zhang, Y., Sirin, O., Corn, P. G., Li-Ning-Tapia, E. M., Troncoso, P., Davis, J., Pettaway, C., Ward, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11674 · Cited by 160
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
Ren, J., Smid, M., Iaria, J., Salvatori, D. C. F., van Dam, H., Zhu, H. J., Martens, J. W. M., & ten Dijke, P. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1194-0 · Cited by 160
Xu, H., Zhao, J., Li, J., Zhu, Z., Cui, Z., Liu, R., Lu, R., Yao, Z., & Xu, Q. M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04935-1 · Cited by 160
“CCL5, a significant member of chemotactic cytokines, plays an important role in CAFs promoting tumor development [18, 19].”
BackgroundGuilloton, F., Caron, G., Ménard, C., Pangault, C., Amé-Thomas, P., Dulong, J., De Vos, J., Rossille, D., Henry, C., Lamy, T., et al. (2012) · Blood · doi:10.1182/blood-2011-08-370908 · Cited by 159
“4 pg/mL [5-4413] versus 33.”
Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic
Oskowitz, A., McFerrin, H., Gutschow, M., Carter, M. L., & Pochampally, R. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.01.004 · Cited by 159
“have been shown to function as stromal cells in solid tumors [11] and vascular stromal cells in wound healing models [12,13].”
BackgroundHaga, H., Yan, I. K., Takahashi, K., Wood, J., Zubair, A., & Patel, T. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.24900 · Cited by 159
Neuroinflammation, Bone Marrow Stem Cells, and Chronic Pain
Huh, Y., Ji, R.-R., & Chen, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01014 · Cited by 159
“Many studies have shown that BMSCs exhibit anti-tumor effects and inhibit tumor growth (55, 56), whereas other studies have suggested the role of protumor effects (57, 58).”
ResultEpithelial plasticity, cancer stem cells and bone metastasis formation
van der Pluijm, G. (2010) · Bone · doi:10.1016/j.bone.2010.07.023 · Cited by 159
“Furthermore, an emerging concept suggests the stroma is not just an innocent bystander, but rather the site of primary dysfunction, which may be critical for carcinogenesis [26– 29,54,84].”
BackgroundMetastasis: new perspectives on an old problem
Pavelić, S. K., Sedić, M., Bosnjak, H., Spaventi, Š., & Pavelić, K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-22 · Cited by 159
“According to this, epithelial cells might be somehow “induced” to become metastatic by several factors such as chemokine CCL5 [31] and transcription factors FOXC2, Twist, Snug, Snail and ZEB1 [13,32] that were shown to drive the EMT programme.”
BackgroundCancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Melzer, C., von der Ohe, J., Lehnert, H., Ungefroren, H., & Hass, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0595-x · Cited by 148
“Production and release of CCL5 by MSC has been suggested to activate corresponding receptors such as CCR5 on adjacent breast cancer cells thereby promoting altered breast cancer development and metastasis [107].”
BackgroundGarcía-Castro, J., Alemany, R., Cascalló, M., Martínez‐Quintanilla, J., Arriero, M., Lassaletta, Á., Madero, L., & Ramírez, M. R. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.4 · Cited by 160
Adipose tissue‐derived stem cells promote prostate tumor growth
Prantl, L., Muehlberg, F., Navone, N. M., Song, Y., Vykoukal, J., Logothetis, C. J., & Alt, E. U. (2010) · The Prostate · doi:10.1002/pros.21206 · Cited by 158
“Furthermore, bone marrow-derived human MSCs, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly in a tumor xenograft model [8].”
BackgroundCancer stem cells and tumor metastasis
LI, S., & LI, Q. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2362 · Cited by 145
“MSCs can infiltrate tumors and may enhance breast cancer cell metastasis (37).”
Background3D Bioprinting of Breast Cancer Models for Drug Resistance Study
Wang, Y., Shi, W., Kuss, M., Mirza, S., Qi, D., Krasnoslobodtsev, A., Zeng, J., Band, H., Band, V., & Duan, B. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01277 · Cited by 157
Yan, X., Fu, C., Chen, L., Qin, J., Zeng, Q., Yuan, H., Nan, X., Chen, H., Zhou, J., Lin, Y.-L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1577-0 · Cited by 157
“RT-PCR analysis showed that BC-MSCs expressed many growth factors including EGF, IL-6, bFGF, HGF, SDF-1a, TGF-b1, BMP4, CCL5, CTGF, IGF-I, IGF-II, Gremlin1, and OPN.”
InfluentialHuang, X., Bai, X., Cao, Y., Wu, J., Huang, M., Tang, D., Tao, S., Zhu, T., Liu, Y., Yang, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090397 · Cited by 156
“Previous well-known mechanisms of immune evasion by tumors involve several factors, such as tumor cells, T reg cells, dendritic cells, and mesenchymal stem cells (Kim et al., 2006; Karnoub et al., 2007).”
BackgroundPinilla, S., Alt, E., Abdul Khalek, F. J., Jotzu, C., Muehlberg, F., Beckmann, C., & Song, Y.-H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.013 · Cited by 156
Wang, S., Liu, S., Sun, H., Huang, T., Chan, C.-H., Yang, C., Yeh, H., Huang, Y., Chou, W., Lin, Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu218 · Cited by 156
“Furthermore, CCL5–CCR5 interaction was highlighted and reported to promote breast cancer metastasis in tumor microenvironment (43).”
BackgroundElia, C. A., Tamborini, M., Rasile, M., Desiato, G., Marchetti, S., Swuec, P., Mazzitelli, S., Clemente, F., Anselmo, A., Matteoli, M., et al. (2019) · Cells · doi:10.3390/cells8091059 · Cited by 139
“More recently the discovery of Extracellular Vesicles (EVs) originating from MSCs, retaining most of the properties of the cells of origin, is leading scientists to develop cell-free therapies to limit the potential side effects associated with the use of stem cells [14], including induction of vascular obstruction [1…”
BackgroundInfluentialMultipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies
Casiraghi, F., Remuzzi, G., Abbate, M., & Perico, N. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9345-4 · Cited by 160
“This effect was not observed when MSC and tumor cells were implanted in separate sites [35].”
InfluentialControversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G. T., & Kassem, M. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.004 · Cited by 155
“In a breast cancer xenograft model, though having no effect on tumor growth per se, MSC greatly increased the metastasis rate through secretion of CCL5 (also called RANTES)(Karnoub et al., 2007).”
BackgroundHu, K., Zhou, H., Liu, Y., Liu, Z., Liu, J., Tang, J., Li, J., Zhang, J., Sheng, W., Zhao, Y., et al. (2015) · Nanoscale · doi:10.1039/c5nr01084e · Cited by 157
Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
Cheng, H., Kastrup, C. J., Ramanathan, R., Siegwart, D. J., Ma, M., Bogatyrev, S. R., Xu, Q., Whitehead, K. A., Langer, R., & Anderson, D. G. (2010) · ACS Nano · doi:10.1021/nn901319y · Cited by 145
Akiyama, K., Ohga, N., Hida, Y., Kawamoto, T., Sadamoto, Y., Ishikawa, S., Maishi, N., Akino, T., Kondoh, M., Matsuda, A., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.029 · Cited by 154
Wu, W. K. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, C. W., Fan, D., Wu, K., Yu, J., Sung, J. J. Y., & Cho, C. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25489 · Cited by 136
“However, in xenograft tumor models, exogenously delivered MSCs are rarely found surrounding blood vessels and mainly contribute to the fibroblast or myofibroblast population.(40,48,49) We found that LL-37 is directly involved in recruitment of MSCs to tumors through a GPCR—possibly FPR2.”
BackgroundQin, Y., Verdegaal, E. M. E., Siderius, M. H., Bebelman, J. P., Smit, M. J., Leurs, R., Willemze, R., Tensen, C. P., & Osanto, S. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00781.x · Cited by 154
Ding, W., Knox, T. R., Tschumper, R. C., Wu, W., Schwager, S. M., Boysen, J. C., Jelinek, D. F., & Kay, N. E. (2010) · Blood · doi:10.1182/blood-2010-02-269894 · Cited by 142
“Other studies showed that coinjection of MSC with tumor cells promotes tumor growth in vivo and metastasis.(27) Recently, Mishra, et al.”
ResultMolloy, A. P., Martin, F. T., Dwyer, R. M., Griffin, T. P., Murphy, M., Barry, F. P., O'Brien, T., & Kerin, M. J. (2009) · International Journal of Cancer · doi:10.1002/ijc.23939 · Cited by 128
“The role of MSCs in metastases has been further investigated in an extensive study by Karnoub et al.(26) This study highlighted the intricate role that MSCs play in metastatic progression of circulat-”
BackgroundInfluentialRole of chemokine systems in cancer and inflammatory diseases
Li, H., Wu, M., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.147 · Cited by 152
Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10199-2 · Cited by 151
Carcinoma-associated fibroblasts provide operational flexibility in metastasis
Wever, O. D., Bockstal, M. V., Mareel, M., Hendrix, A., & Bracke, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.009 · Cited by 151
Maximal T Cell–Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
González-Martín, A., Gómez, L., Lustgarten, J., Mira, E., & Mañes, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1687 · Cited by 137
“Evidence also implicates CCR5 in the induction of proliferation, metastasis, and angiogenesis (14, 15), supporting its protumorigenic role.”
BackgroundUnderstanding the role of the kynurenine pathway in human breast cancer immunobiology
Heng, B., Lim, C. K., Lovejoy, D. B., Bessede, A., Gluch, L., & Guillemin, G. J. (2016) · Oncotarget · doi:10.18632/oncotarget.6467 · Cited by 137
“Increased KP enzymes mRNA expression in invasive breast carcinoma was also observed in the European Molecular Biology laboratory Gene Expression Atlas (EMBL; Table 1C) [122-125].”
BackgroundThe Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T., Ogawa, R., Taketo, M., & Sakai, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050643 · Cited by 132
Exosomes and exosomal RNAs in breast cancer: A status update
Lakshmi, S., Hughes, T. A., & Priya, S. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.033 · Cited by 152
Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
“For example, IL-6 and CCL5, proteins produced by MSCs, have been shown to increase the growth and metastasis of breast cancer cells, respectively (Karnoub et al., 2007; Sasser et al., 2007).”
Pancreatic cancer stromal biology and therapy
Xie, D., & Xie, K. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.01.002 · Cited by 138
“Also, Karnoub et al reported that tumor cells recruit MSCs to tumor xenografts(54) and are addicted to the chemokine CCL5 secreted from MSCs for their metastatic spread.(71) The ability of MSCs to travel to solid tumors after intravenous administration further supports that activated hPSCs are derived from MSCs.”
BackgroundThe network of epithelial–mesenchymal transition: potential new targets for tumor resistance
Nantajit, D., Lin, D., & Li, J. J. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1840-y · Cited by 152
“The mixture between mesenchymal stem cells and metastatic tumor cells greatly enhances tumor metastatic potential through the communication between the two types of cells utilizing CCR5, a chemokine receptor involved in binding interaction with the gp120 HIV-1 envelope glycoprotein (Karnoub et al. 2007).”
Background
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.